Target intelligence / Profile preview

Toxic bile acid levels

Molecular classification
Other
01

Overview

“Toxic bile acid levels” is not a molecule or molecular target, but rather a pathological state arising when bile acids—which are amphipathic steroids produced by the liver to aid in fat digestion and cholesterol excretion—accumulate to abnormally high, cytotoxic concentrations in tissues or plasma. Bile acids are essential for normal digestion, but when their hepatic, biliary, or intestinal regulation fails (such as in cholestasis, ileal disease, or genetic bile acid synthesis disorders), their accumulation can damage hepatocytes, inflame the gastrointestinal tract, cause malabsorption, and contribute to disease progression in chronic liver conditions. Although drugs (e.g., bile acid sequestrants, ursodeoxycholic acid) aim to mitigate the toxic effects of excessive bile acids, “toxic bile acid levels” itself does not refer to a discrete target but rather a measurable disease process or biomarker. Caveat: “Toxic bile acid levels” is not a canonical molecular target (such as a receptor or enzyme), but a clinical/biochemical phenomenon, so this entry is better classified as a disease biomarker or pathophysiological state rather than a discrete drug target molecule.

Other names
Bile acid overloadElevated bile acidsHigh bile acid levels
02

Mechanism of action

Bile acid sequestrants (bind/neutralize bile acids in the gut to prevent toxic effects and diarrhea) Replacement of toxic with less toxic bile acids (e.g., ursodeoxycholic acid displaces more toxic bile acids)

03

Biological functions

Other
04

Disease associations

Liver diseaseCholestasisBile acid malabsorptionFat malabsorptionCirrhosisOther
05

Safety considerations

Safety concerns with bile acid sequestrants: gastrointestinal side effects (constipation, bloating, gas), poor palatabilityRisk of vitamin malabsorption (especially fat-soluble vitamins: A, D, E, K)Potential for liver injury, cirrhosis, and organ dysfunction due to prolonged toxicity
06

Interacting drugs

Cholestyramine

4 more in the full profile.

07

Biomarkers

Serum total bile acidsFecal bile acid levelsLiver function tests (including markers for cholestasis)

Beyond the preview

Go deeper on Toxic bile acid levels.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Toxic bile acid levels.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call